Pedro Valencia

Pedro Valencia, PhD has an extensive background in the pharmaceutical and biotechnology industry. With experience at AbbVie and the Boston Consulting Group, Pedro has worked on strategic projects ranging from immuno-oncology to hepatitis C elimination. Prior to that, Pedro conducted research at MIT, resulting in the formation of Tarveda Therapeutics. Pedro has also provided scientific consulting for various companies, showcasing their expertise in the field. Pedro's educational background includes a Doctor of Philosophy (PhD) in Chemical Engineering from MIT and previous degrees from the same institution and the University of Wisconsin-Madison.